Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome
Tóm tắt
Evidence suggests impairment in aspects of cognitive function in women with polycystic ovary syndrome (PCOS). Direct effects of raised testosterone levels associated with PCOS are a potential mechanism. We aimed to explore the relationship between testosterone levels and cognitive functioning in women. Women with a range of testosterone levels, including women with PCOS, were recruited. Depressive and anxiety symptoms were measured by self-report. Participants underwent a comprehensive battery of cognitive tests assessing psychomotor speed, visuospatial learning and memory, verbal learning and memory, and executive function. Free testosterone serum levels were assessed. All measures were completed at the same time point. Correlation analysis (Spearman’s Rho) was used to explore associations between free testosterone and cognitive test variables. Eighty-one women were recruited, with 40 meeting diagnostic criteria for PCOS. Free testosterone was normally distributed, with significant overlap between women with PCOS and controls. Mean depressive and anxiety symptoms were in the mild range. Higher free testosterone levels were significantly correlated with poorer performance on measures assessing psychomotor speed and visuospatial learning. These significant correlations remained after adjusting for confounders (premorbid verbal IQ, depressive, and anxiety symptoms). Higher free testosterone levels in women were associated with poorer cognitive function, specifically psychomotor speed and visuospatial learning. Women with PCOS and raised free testosterone levels may experience impairment in these aspects of cognitive function which are not accounted for by mood or anxiety symptoms.
Tài liệu tham khảo
Barnard L, Balen AH, Ferriday D, Tiplady B, Dye L (2007) Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology 32:906–914
Barry J, Parekh H, Hardiman P (2013) Visual-spatial cognition in women with polycystic ovarian syndrome: the role of androgens. Hum Reprod 28:2832–2837
Benton AL, Hamsher K (1989) Multilingual aphasia examination. AJA Associates, Iowa City, IA
Beyenburg S, Watzka M, Clusmann H, Blümcke I, Bidlingmaier F, Elger CE, Stoffel-Wagner B (2000) Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett 294:25–28
Blair JA, Bhatta S, McGee H, Casadesus G (2015) Luteinizing hormone: evidence for direct action in the CNS. Horm Behav 76:57–62
Bourke C, Porter RJ, Carter JD, McIntosh VV, Jordan J, Bell C, Carter F, Colhoun H, Joyce PR (2012) Comparison of neuropsychological functioning and emotional processing in major depression and social anxiety disorder subjects, and matched healthy controls. Aust NZ J Psychiatry 46:972–981
Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:P1–P29
Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32:1075–1091
Corsi, P., 1972. Human memory and the medial temporal region of the brain [PhD thesis]. Montreal: McGill University, Montreal.
Douglas K, Porter R, Knight R, Maruff P (2011) Neuropsychological changes and treatment response in severe depression. Br J Psychiatry 198:115–122
Elder P, Lewis J (1985) An enzyme-linked immunosorbent assay (ELISA) for plasma testosterone. J Steroid Biochem 22:635–638
Hsu KJ, Young-Wolff KC, Kendler KS, Halberstadt LJ, Prescott CA (2014) Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: a monozygotic discordant twin-pair study. Psychiatry Res 215:87–94
Huang A, Brennan K, Azziz R (2010) Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 93:1938–1941
Jarrett BY, Vantman N, Mergler RJ, Brooks ED, Pierson RA, Chizen DR, Lujan ME (2019) Dysglycemia, not altered sex steroid hormones, affects cognitive function in polycystic ovary syndrome. Journal of the Endocrine Society 3:1858–1868
Keevil BG, Adaway J, Fiers T, Moghetti P, Kaufman JM (2018) The free androgen index is inaccurate in women when the SHBG concentration is low. Clin Endocrinol (oxf) 88:706–710
Lewis JG, Longley NJ, Elder PA (1999) Monoclonal antibodies to human sex hormone-binding globulin (SHBG): characterization and use in a simple enzyme-linked immunosorbent assay (ELISA) of SHBG in plasma. Steroids 64:259–265
Lezak MD (2004) Neuropsychological assessment. Oxford University Press, USA
Luine VN (2014) Estradiol and cognitive function: past, present and future. Horm Behav 66:602–618
Nelson, H.E., Willison, J., 1991. National adult reading test (NART). Nfer-Nelson Windsor.
Pintzka CW, Evensmoen HR, Lehn H, Håberg AK (2016) Changes in spatial cognition and brain activity after a single dose of testosterone in healthy women. Behav Brain Res 298:78–90
Porter R, Bourke C, Gallagher P (2007) Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 41:115–128
Postma A, Meyer G, Tuiten A, van Honk J, Kessels RP, Thijssen J (2000) Effects of testosterone administration on selective aspects of object-location memory in healthy young women. Psychoneuroendocrinology 25:563–575
Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276
Rock PL, Roiser JP, Riedel WJ, Blackwell AD (2013) Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44:2029–2040
Rosenberg L, Park S (2002) Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 27:835–841
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
Sarrieau A, Mitchell JB, Lal S, Olivier A, Quirion R, Meaney MJ (1990) Androgen binding sites in human temporal cortex. Neuroendocrinology 51:713–716
Schattmann L, Sherwin BB (2007) Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav 51:587–596
Sheehan M, Lecrubier Y, Sheehan K, Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G (1998) Diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33
Snyder PJ, Bednar MM, Cromer JR, Maruff P (2005) Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor. Alzheimers Dement 1:126–135
Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P (2008) Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res 160:316–326
SPSS (2004) Statistical Package for the Social Sciences. SPSS Inc, Chicago, IL
Symonds C, Gallagher P, Thompson J, Young A (2004) Effects of the menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy premenopausal women. Psychol Med 34:93–102
Tiffin J (1968) Purdue Pegboard examiner manual. Science Research Associates. Inc., Chicago, Illinois
Valderhaug TG, Hertel JK, Nordstrand N, Dale PO, Hofsø D, Hjelmesæth J (2015) The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women. Diabetol Metab Syndr 7:46
Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370